Diagnostic testing for diabetes using HbA 1cin the Abu Dhabi population - Weqaya: The Abu Dhabi cardiovascular screening Program

Diabetes Care

Volumn 34, Issue 11, 2011, Pages 2400-2402

  Hajat, Cother ^a   Harrison, Oliver ^a   Al Siksek, Zaid ^a  

^a Health Authority Abu Dhabi   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASS SCREENING; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UNITED ARAB EMIRATES; VALIDATION PROCESS; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH SURVEY; MALE; METABOLISM; METHODOLOGY; REPRODUCIBILITY; STANDARD; VALIDATION STUDY; WORLD HEALTH ORGANIZATION;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIAGNOSTIC TESTS, ROUTINE; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; POPULATION SURVEILLANCE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UNITED ARAB EMIRATES; WORLD HEALTH ORGANIZATION;

EID: 84857074092     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0284     Document Type: Article

References (15)

1. WHO Statistical Information System1 (WHOSIS) data [Internet]. Available from http://apps.who.int/whosis/data. Accessed 6 January 2010
2. International Diabetes Federation. The Diabetes Atlas. 4th ed. [Internet], 2009. Available from http://atlas.idf-bxl.org. Accessed 6 January 2010
3. Hajat C, Harrison O. The Abu Dhabi Cardiovascular Program: the continuation of Framingham. Prog Cardiovasc Dis 2010;53:28-38
4. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
6. HAAD. 2010 Statistics Report [Internet], 2010. Available from www.HAAD.ae/statistics. Accessed 6 June 2011
7. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation [Internet], 2006. Available fromhttp://www.idf.org/webdata/docs/WHO-IDF-definition- diagnosis-of-diabetes.pdf. Accessed 6 January 2010
8. American Diabetes Association. Standards of medical care in diabetes: 2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
9. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-524 (Pubitemid 28172927)
10. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
11. Bao Y, Ma X, Li H, et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010;340:c2249
12. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007;30:2233-2235 (Pubitemid 47359021)
13. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006;295:1688-1697
14. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-2453 (Pubitemid 352008502)
15. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010;152:770-777